News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
American Diabetes Association Announces Retirement of Chief Scientific & Medical Officer, Dr. Richard Kahn
December 17, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ALEXANDRIA, VA--(Marketwire - December 16, 2008) - The American Diabetes Association announced today that Richard A. Kahn, PhD, its Chief Scientific and Medical Officer, will be retiring in June 2009.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Artificial intelligence
Merck adds to biopharma’s AI agenda with up to $510M+ Protillion pact
June 17, 2026
·
2 min read
·
Tristan Manalac
Podcast
Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more
June 17, 2026
·
2 min read
·
Jef Akst
Layoff Tracker
Neumora, enGene cut staff in cost-saving initiatives
June 16, 2026
·
61 min read
·
BioSpace Editorial Staff
Drug Development
Neumora discards depression asset, lays off staffers after pair of late-stage flops
June 15, 2026
·
2 min read
·
Gabrielle Masson